Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating CART133 for relapsed/chemo-refractory advanced malignancies completed, across multiple cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Brain Tumor
• Breast Cancer
• Colorectal Cancer
• Liver Cancer
• Lymphoid Leukemia
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• CART133 (not specified)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Liver Cancer, Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED